Loading…
A bill to withhold United States contributions to the United Nations until the United Nations formally retracts the final report of the "United Nations Fact Finding Mission on the Gaza Conflict".
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,002 other S bills in the 113th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2015 · first_quarter · Taxation/Internal Revenue Code
- S. 1706, Fair Playing Field Act of 2013, provisions related to amending P.S. 95-600; - The Revenue Act of 1978, Section 530, which protects small business ownership and entrepreneurship for independent contractors; no bill number, preserving retirement savings tax incentives in the current tax code
Client expense: Not reported · Firm income: $80,000
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Taxation/Internal Revenue Code
S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax); S.2360/ H.R.4679 The Stop Corporate Inversions Act of 2014 (Provisions related to management and control); H.R.4985 - Stop Corporate Expatriation and Invest in America's Infrastructure Act of 2014 (Provisions related to management and control);S. 2786 Corporate Inverters Earnings Stripping Reform Act;
Client expense: $580,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Taxation/Internal Revenue Code
S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax); S.2360/ H.R.4679 The Stop Corporate Inversions Act of 2014 (Provisions related to management and control); H.R.4985 - Stop Corporate Expatriation and Invest in America's Infrastructure Act of 2014 (Provisions related to management and control);S. 2786 Corporate Inverters Earnings Stripping Reform Act;
Client expense: $550,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2014 · second_quarter · Taxation/Internal Revenue Code
S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).S.2360/ H.R.4679 The Stop Corporate Inversions Act of 2014 (Provisions related to management and control); H.R.4985 - Stop Corporate Expatriation and Invest in America's Infrastructure Act of 2014 (Provisions related to management and control)
Client expense: $510,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2014 · first_quarter · Taxation/Internal Revenue Code
S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).
Client expense: $550,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Taxation/Internal Revenue Code
S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).
Client expense: $530,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Taxation/Internal Revenue Code
S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).
Client expense: $450,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Taxation/Internal Revenue Code
S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).
Client expense: $470,000 · Firm income: Not reported
Government targets: Energy, Dept of, Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS)
2013 · second_quarter · Taxation/Internal Revenue Code
S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).
Client expense: $760,000 · Firm income: Not reported
Government targets: Energy, Dept of, Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS)